Cancer HealthCast: NCI Program Unlocks Emerging Proteomic Data to Advance Precision Medicine
Researchers say sharing molecular cancer research data can expand cancer treatment and care.
Proteomics is an emerging field in cancer care and research. The National Cancer Institute’s Clinical Proteomic Tumor Analysis Consortium (CPTAC) aims to get to the heart of cancer by studying its molecular basis across different cancers. The group believes expanding open-source resources and other data can lead to new treatments in cancer and expand precision medicine.
Dr. Henry Rodriguez, the founding director of the Office of Cancer Clinical Proteomics Research at NCI, discusses the program and how the related International Cancer Proteogenome Consortium (ICPC) is helping researchers pull together resources necessary to innovate cancer care.
-
Dr. Henry Rodriguez Founding Director, Office of Cancer Clinical Proteomics Research NCI
-
Rising Threats Push Agencies to Revamp Cyber Defenses
NIST and DHMS officials boost data security with the evolution of CSF 2.0 and push toward attribute-based access control amid the rise of AI.
3m read -
Driving Mission Impact with Scalable AI
IT leaders explore AI innovation, development and integration into cloud environments to drive operational excellence.
15m watch -
Kratsios Brings AI, 5G, Future Tech to OSTP Forefront
The former federal CTO's return to the White House signals renewed push for U.S. innovation in emerging technology.
3m read -
Navy’s MOSA 1.0 Boosts Innovation, Interoperability
The Navy’s Modular Open Systems Architecture enables rapid prototyping, tech adoption and sharing of best practices across the Defense Department.
14m watch
